However, the method of activation seems to differ from mutation of exon 3 of CTNNB1. The data has also revealed a potential link between survival and the extent of pathway activation in CNS PNETs. The gene discussed is CTNNB1; the disease is central nervous system primitive neuroectodermal neoplasm.